Arcellx (ACLX) Change in Acquisitions & Divestments (2022 - 2025)
Arcellx's (ACLX) quarterly Change in Acquisitions & Divestments came in at $108.2 million in Q4 2025, down 19.07% year-on-year from $133.7 million in Q4 2024, and up 5.66% quarter-over-quarter from $102.4 million in Q3 2025.
Arcellx (ACLX) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
Arcellx's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $108.2 million for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments fell 19.07% year-over-year to $108.2 million in Q4 2025; TTM through Dec 2025 was $495.6 million, a 15.88% increase from a year earlier, with the FY2025 full-year figure at $495.6 million, up 15.88% from the prior year.
- Change in Acquisitions & Divestments rose to $108.2 million in Q4 2025 per ACLX's latest filing, from $102.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $167.8 million in Q2 2025 and bottomed at $16.8 million in Q1 2022.
- The 4-year median for Change in Acquisitions & Divestments is $91.1 million (2023), against an average of $86.9 million.
- Across the five-year window, Change in Acquisitions & Divestments jumped 471.81% in 2023 and declined 19.07% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $60.7 million in 2022, then increased by 13.26% to $68.7 million in 2023, then jumped by 94.63% to $133.7 million in 2024, then slipped by 19.07% to $108.2 million in 2025.
- Per Business Quant, the three latest ACLX Change in Acquisitions & Divestments figures stand at $108.2 million (Q4 2025), $102.4 million (Q3 2025), and $167.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108.20 Mn |
| Dec 31, 2025 | 108.20 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Jun 30, 2025 | 167.80 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Mar 31, 2025 | 117.20 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Dec 31, 2024 | 133.70 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Sep 30, 2024 | 98.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Mar 31, 2024 | 118.00 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Dec 31, 2023 | 68.70 Mn |
| Sep 30, 2023 | 85.80 Mn |
| Sep 30, 2023 | 85.80 Mn |